Free Trial

Aprea Therapeutics (APRE) Insider Trading & Ownership

Aprea Therapeutics logo
$0.84 +0.00 (+0.29%)
Closing price 04:00 PM Eastern
Extended Trading
$0.81 -0.04 (-4.41%)
As of 05:43 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Aprea Therapeutics (NASDAQ:APRE) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
13.63%
Number Of
Insiders Buying
(Last 12 Months)
2
Amount Of
Insider Buying
(Last 12 Months)
$30.96K
Number Of
Insiders Selling
(Last 12 Months)
0
Get APRE Insider Trade Alerts

Want to know when executives and insiders are buying or selling Aprea Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

APRE Insider Buying and Selling by Quarter

Aprea Therapeutics Insider and Congressional Trades History

Transaction DateInsiderBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
12/10/2025
John P Hamill
CFO
Buy5,000$1.17$5,850.00  
12/10/2025
Marc Duey
Director
Buy21,459$1.17$25,107.03  
(Data available from 1/1/2013 forward)

APRE Insider Trading Activity - Frequently Asked Questions

The list of insiders at Aprea Therapeutics includes Bernd R Seizinger, John P Hamill, Marc Duey, and Oren Gilad. Learn more on insiders at APRE.

13.63% of Aprea Therapeutics stock is owned by insiders. Learn more on APRE's insider holdings.

The following insiders have purchased APRE shares in the last 24 months: Bernd R Seizinger ($26,800.00), John P Hamill ($7,024.50), Marc Duey ($157,297.23), and Oren Gilad ($15,051.00).

Insiders have purchased a total of 74,249 APRE shares in the last 24 months for a total of $206,172.73 bought.

The following insider sold APRE shares in the last 24 months: Marc Duey ($29,595.96).

Insiders have sold a total of 6,462 Aprea Therapeutics shares in the last 24 months for a total of $29,595.96 sold.



This page (NASDAQ:APRE) was last updated on 5/5/2026 by MarketBeat.com Staff.
From Our Partners